Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 12 min ago
Peer-reviewedCC BY-NC-ND 4.0Blood Advances

The loss of miR-146a-5p contributes to ibrutinib resistance in mantle cell lymphoma∗

  • Olga Kersy1,2
  • Nir Cohen1,2
  • Mali Salmon-Divon1,3
  • Pavel Klener4,5
  • Katarina Mekin2
  • Tal Zvida-Bloch1,2
  • Maria Gomes da Silva6
  • Filipa Moita6
  • Jose Cabecadas7
  • Marek Trněný4
  • May Basood8
  • Martin Dreyling9
4 more authors
  • Benjamin H. Durham10
  • Omar Abdel-Wahab10
  • Ofer Shpilberg2,3,8
  • Oshrat Hershkovitz-Rokah1,2
10 affiliations
  1. 1Department of Molecular Biology, Faculty of Natural Sciences, Ariel University, Ariel, Israel
  2. 2Translational Research Lab, Assuta Medical Center, Tel Aviv, Israel
  3. 3Adelson School of Medicine, Ariel University, Ariel, Israel
  4. 4First Department of Internal Medicine-Hematology, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
  5. 5First Faculty of Medicine, Institute of Pathological Physiology, Charles University, Prague, Czech Republic
  6. 6Department of Hematology, Instituto Português de Oncologia de Lisboa, Lisbon, Portugal
  7. 7Department of Pathology, Instituto Português de Oncologia de Lisboa, Lisbon, Portugal
  8. 8Institute of Hematology, Assuta Medical Center, Tel Aviv, Israel
  9. 9Department of Medicine III, University Hospital, Ludwig Maximilian University, Munich, Germany
  10. 10Molecular Pharmacology Program, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
Read full textPDFDOICite

Related

  1. Progressive Pancytopenia in the Setting of Severe Pneumonia in a Patient With a History of Mantle Cell Lymphoma: A Case Report
    Soshiant Raeesian, Sohrab R Mardani, Oscar Castillo +2
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Contemporary Treatment and Survival Outcomes in Mantle Cell Lymphoma: A National Real‐World Analysis From REALYSA, a LYSA Cohort
    Morgane Cheminant, Patrick Fogarty, Sylvain Carras +31
    Hematological OncologyPeer-reviewedCC BY-NC 4.0Full textGeneral biologyEpidemiology & public healthHAL
  3. Socioeconomic deprivation does not affect survival outcomes in patients with mantle cell lymphoma: evidence from a German nationwide study.
    Susanne von Kroge, Sabrina Klotz, Hanna Walk +5
    Blood cancer journalPeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
  4. Real‐World Treatment Patterns, Burden of Illness, and Survival of Autologous Stem Cell Transplant‐Ineligible Patients With Mantle Cell Lymphoma in Ontario, Canada
    Sydney George, Soo Jin Seung, Sandra Thibault +3
    EJHaemPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMCDOAJ
  5. AUTOLOGOUS STEM CELL TRANSPLANTATION REMAINS AN EFFECTIVE STRATEGY IN MANTLE CELL LYMPHOMA IN A BRAZILIAN REAL-WORLD COHORT
    Lara GALLUCCI FIGORELLE, Ruddy DALFEOR, Valéria VIANNA +14
    Hematology, Transfusion and Cell TherapyPeer-reviewedCC BYFull textEndocrinology & metabolismDOAJ

Cite

BibTeXRIS
BibTeX
@article{kersy2026loss,
  title = {{The loss of miR-146a-5p contributes to ibrutinib resistance in mantle cell lymphoma∗}},
  author = {Olga Kersy and Nir Cohen and Mali Salmon-Divon and Pavel Klener and Katarina Mekin and Tal Zvida-Bloch and Maria Gomes da Silva and Filipa Moita and Jose Cabecadas and Marek Trněný and May Basood and Martin Dreyling and Benjamin H. Durham and Omar Abdel-Wahab and Ofer Shpilberg and Oshrat Hershkovitz-Rokah},
  journal = {Blood Advances},
  year = {2026},
  month = jun,
  doi = {10.1182/bloodadvances.2025016640},
  url = {https://doi.org/10.1182/bloodadvances.2025016640},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - The loss of miR-146a-5p contributes to ibrutinib resistance in mantle cell lymphoma∗
AU  - Olga Kersy
AU  - Nir Cohen
AU  - Mali Salmon-Divon
AU  - Pavel Klener
AU  - Katarina Mekin
AU  - Tal Zvida-Bloch
AU  - Maria Gomes da Silva
AU  - Filipa Moita
AU  - Jose Cabecadas
AU  - Marek Trněný
AU  - May Basood
AU  - Martin Dreyling
AU  - Benjamin H. Durham
AU  - Omar Abdel-Wahab
AU  - Ofer Shpilberg
AU  - Oshrat Hershkovitz-Rokah
PY  - 2026
DA  - 2026/06/25
JO  - Blood Advances
DO  - 10.1182/bloodadvances.2025016640
UR  - https://doi.org/10.1182/bloodadvances.2025016640
SN  - 2473-9529
SN  - 2473-9537
ER  -